• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Lifecare

Less than 1K followers

LIFE

Oslo Børs

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus

Lifecare is a Norwegian company operating in medical technology. The company specializes in research and development of solutions for diabetes. The microsensors are injected under the skin of the patient's wrist, and also function as a real-time update of the patient's glucose level. In addition, the technology provides an alarm sensor and access to historical data on the patient's glucose level. The company was established in 2006 and is headquartered in Bergen, Norway.

Read more
Market cap
-
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
19.8.
2026

Interim report Q2'26

12.11.
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Regulatory press release6/12/2026, 3:30 PM

Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue

Lifecare
Regulatory press release6/12/2026, 5:00 AM

Lifecare ASA: Last day of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue

Lifecare
Regulatory press release6/11/2026, 6:10 AM

Lifecare ASA: Mandatory notification of trade

Lifecare

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release6/10/2026, 2:11 PM

Lifecare ASA: Mandatory notification of trade

Lifecare
Regulatory press release6/10/2026, 5:00 AM

LIFE: Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response

Lifecare
Press release6/10/2026, 5:00 AM

Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response

Lifecare
Regulatory press release6/5/2026, 5:00 AM

Lifecare ASA: Last day of trading in Warrants Series 2 issued in connection with the Rights Issue

Lifecare
Regulatory press release6/3/2026, 11:15 AM

Lifecare ASA: Mandatory notification of trade

Lifecare
Regulatory press release6/1/2026, 5:00 AM

Lifecare ASA: Commencement of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue

Lifecare
Regulatory press release5/29/2026, 4:55 PM

Lifecare ASA: Exercise price for Warrants Series 2 issued in connection with the Rights Issue

Lifecare
Press release5/20/2026, 4:44 AM

DNB Carnegie Access: Lifecare ASA: Progress still needs to become visible – Q1 review

Lifecare
Regulatory press release5/19/2026, 8:03 PM

Lifecare ASA: Mandatory notification of trade

Lifecare
Regulatory press release5/15/2026, 5:00 AM

LIFE: Lifecare ASA Q1 2026 results

Lifecare
Regulatory press release5/7/2026, 4:30 PM

Lifecare ASA (LIFE): Invitation to Q1 2026 results presentation

Lifecare
Press release5/7/2026, 4:30 PM

Lifecare ASA (LIFE): Invitation to Q1 2026 results presentation

Lifecare
Regulatory press release5/7/2026, 4:27 PM

LIFE: Financial calendar

Lifecare
Regulatory press release4/23/2026, 8:58 AM

Minutes from Annual General meeting 2026

Lifecare
Regulatory press release4/1/2026, 8:00 PM

Annual General Meeting

Lifecare
Regulatory press release4/1/2026, 9:27 AM

LIFE: Disclosure of shareholding

Lifecare
Regulatory press release3/27/2026, 10:21 AM

Shareholding disclosure - Nordnet AB (publ) 2

Lifecare